|
1）Kurtz SM, Ochoa JA, Lau E, et al. Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the united states: 1993-2006. Pacing Clin Electrophysiol. 2010; 33: 705-11
|
|
|
|
2）Greenspon AJ, Patel JD, Lau E, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the united states 1993 to 2008. J Am Coll Cardiol. 2011; 58: 1001-6
|
|
|
|
|
|
3）Osmonov D, Ozcan KS, Erdinler I, et al. Cardiac device-related endocarditis: 31-years' experience. J Cardiol. 2013; 61: 175-80
|
|
|
|
|
4）Mela T, McGovern BA, Garan H, et al. Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter- defibrillator implants. Am J Cardiol. 2001; 88: 750-3
|
|
|
|
|
|
5）Athan E, Chu VH, Tattevin P, et al. Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. JAMA. 2012; 307: 1727-35
|
|
|
|
|
|
6）Kim DH, Tate J, Dresen WF, et al. Cardiac implanted electronic device-related infective endocarditis: Clinical features, management, and outcomes of 80 consecutive patients. Pacing Clin Electrophysiol. 2014; 37: 978-85
|
|
|
|
|
|
7）Ploux S, Riviere A, Amraoui S, et al. Positron emission tomography in patients with suspected pacing system infections may play a critical role in difficult cases. Heart Rhythm. 2011; 8: 1478-81
|
|
|
|
|
|
8）Sarrazin JF, Philippon F, Tessier M, et al. Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. J Am Coll Cardiol. 2012; 59: 1616-25
|
|
|
|
|
|
9）Chamis AL, Peterson GE, Cabell CH, et al. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation. 2001; 104: 1029-33
|
|
|
|
|
|
10）Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: Diagnosis, antimicrobial therapy, and management of complications: A statement for healthcare professionals from the committee on rheumatic fever, endocarditis, and kawasaki disease, council on cardiovascular disease in the young, and the councils on clinical cardiology, stroke, and cardiovascular surgery and anesthesia, american heart association: Endorsed by the infectious diseases society of america. Circulation. 2005; 111: e394-434
|
|
|
|
|
|
11）Bushmitz M, Lecu A, Verreck F, et al. Guidelines for the prevention and control of tuberculosis in non-human primates: Recommendations of the european primate veterinary association working group on tuberculosis. J Med Primatol. 2009; 38: 59-69
|
|
|
|
|
|
12）Habib A, Le KY, Baddour LM, et al. Predictors of mortality in patients with cardiovascular implantable electronic device infections. Am J Cardiol. 2013; 111: 874-9
|
|
|
|
|
|
13）Nielsen JC, Gerdes JC, Varma N. Infected cardiac-implantable electronic devices: Prevention, diagnosis, and treatment. Eur Heart J. 2015; 36: 2484-90
|
|
|
|
|
|
14）Polewczyk A, Jachec W, Janion M, et al. Lead-dependent infective endocarditis: The role of factors predisposing to its development in an analysis of 414 clinical cases. Pacing Clin Electrophysiol. 2015; 38: 846-56
|
|
|
|
|
|
15）Sohail MR, Uslan DZ, Khan AH, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007; 49: 1851-9
|
|
|
|
|
|
16）Graziosi M, Nanni C, Lorenzini M, et al. Role of 18F-FDG pet/ct in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study. Eur J Nucl Med Mol Imaging. 2014; 41: 1617-23
|
|
|
|
|
|
17）Saby L, Laas O, Habib G, et al. Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: Increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion. J Am Coll Cardiol. 2013; 61: 2374-82
|
|
|
|
|
|
18）Kouijzer IJ, Vos FJ, Janssen MJ, et al. The value of 18F-FDG pet/ct in diagnosing infectious endocarditis. Eur J Nucl Med Mol Imaging. 2013; 40: 1102-7
|
|
|
|
|
|
19）Kouijzer IJ, Vos FJ, Janssen MJ, et al. Reply to comment by treglia and bertagna: FDG pet/ct for detection of infectious endocarditis. Eur J Nucl Med Mol Imaging. 2013; 40: 1114-5
|
|
|
|
|
|
20）Dy Chua J, Abdul-Karim A, Mawhorter S, et al. The role of swab and tissue culture in the diagnosis of implantable cardiac device infection. Pacing Clin Electrophysiol. 2005; 28: 1276-81
|
|
|
|
|
|
21）Bongiorni MG, Tascini C, Tagliaferri E, et al. Microbiology of cardiac implantable electronic device infections. Europace. 2012; 14: 1334-9
|
|
|
|
|
|
22）Wilkoff BL, Love CJ, Byrd CL, et al. Transvenous lead extraction: Heart rhythm society expert consensus on facilities, training, indications, and patient management: This document was endorsed by the american heart association (AHA). Heart Rhythm. 2009; 6: 1085-104
|
|
|
|
|
|
23）Klug D, Wallet F, Lacroix D, et al. Local symptoms at the site of pacemaker implantation indicate latent systemic infection. Heart. 2004; 90: 882-6
|
|
|
|
|
|
24）Okamura H, Yasuda S, Sato S, et al. Initial experience using excimer laser for the extraction of chronically implanted pacemaker and implantable cardioverter defibrillator leads in japanese patients. J Cardiol. 2013; 62: 195-200
|
|
|
|
|
|
25）Goyal SK, Ellis CR, Ball SK, et al. High-risk lead removal by planned sequential transvenous laser extraction and minimally invasive right thoracotomy. J Cardiovasc Electrophysiol. 2014; 25: 617-21
|
|
|
|
|
|
26）Lewis RK, Pokorney SD, Greenfield RA, et al. Preprocedural ecg-gated computed tomography for prevention of complications during lead extraction. Pacing Clin Electrophysiol. 2014; 37: 1297-305
|
|
|
|
|
|
27）Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med. 2004; 350: 1422-9
|
|
|
|
|